[HTML][HTML] Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot
EL Barrios, MB Mazer, PW McGonagill, CB Bergmann… - JCI insight, 2024 - ncbi.nlm.nih.gov
BACKGROUND Sepsis remains a major clinical challenge for which successful treatment
requires greater precision in identifying patients at increased risk of adverse outcomes …
requires greater precision in identifying patients at increased risk of adverse outcomes …
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot.
EL Barrios, MB Mazer, PW McGonagill, CB Bergmann… - JCI Insight, 2024 - europepmc.org
BACKGROUND Sepsis remains a major clinical challenge for which successful treatment
requires greater precision in identifying patients at increased risk of adverse outcomes …
requires greater precision in identifying patients at increased risk of adverse outcomes …
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot
EL Barrios, MB Mazer, PW McGonagill, CB Bergmann… - JCI Insight, 2024 - experts.umn.edu
BACKGROUND. Sepsis remains a major clinical challenge for which successful treatment
requires greater precision in identifying patients at increased risk of adverse outcomes …
requires greater precision in identifying patients at increased risk of adverse outcomes …
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot
EL Barrios, DE Del Toro, A Dram, S Meszaros, S Miles… - 2024 - digitalcommons.wustl.edu
BACKGROUND. Sepsis remains a major clinical challenge for which successful treatment
requires greater precision in identifying patients at increased risk of adverse outcomes …
requires greater precision in identifying patients at increased risk of adverse outcomes …
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot
EL Barrios, M Mazer, PW McGonagill, CB Bergmann… - JCI Insight, 2024 - profiles.wustl.edu
BACKGROUND. Sepsis remains a major clinical challenge for which successful treatment
requires greater precision in identifying patients at increased risk of adverse outcomes …
requires greater precision in identifying patients at increased risk of adverse outcomes …
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot
EL Barrios, MB Mazer, PW McGonagill… - JCI …, 2024 - pubmed.ncbi.nlm.nih.gov
BACKGROUNDSepsis remains a major clinical challenge for which successful treatment
requires greater precision in identifying patients at increased risk of adverse outcomes …
requires greater precision in identifying patients at increased risk of adverse outcomes …
Adverse outcomes and an immune suppressed endotype in sepsis patients with reduced interferon-γ ELISpot
EL Barrios, MB Mazer, PW McGonagill, CB Bergmann… - JCI insight, 2024 - iro.uiowa.edu
Sepsis remains a major clinical challenge for which successful treatment requires greater
precision in identifying patients at increased risk of adverse outcomes requiring different …
precision in identifying patients at increased risk of adverse outcomes requiring different …
[HTML][HTML] Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot
EL Barrios, MB Mazer, PW McGonagill… - JCI …, 2024 - Am Soc Clin Investig
BACKGROUND. Sepsis remains a major clinical challenge for which successful treatment
requires greater precision in identifying patients at increased risk of adverse outcomes …
requires greater precision in identifying patients at increased risk of adverse outcomes …
[HTML][HTML] Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot
EL Barrios, MB Mazer, PW McGonagill… - JCI …, 2024 - Am Soc Clin Investig
BACKGROUND. Sepsis remains a major clinical challenge for which successful treatment
requires greater precision in identifying patients at increased risk of adverse outcomes …
requires greater precision in identifying patients at increased risk of adverse outcomes …
Adverse outcomes and an immune suppressed endotype in sepsis patients with reduced interferon-γ ELISpot.
EL Barrios, MB Mazer, PW McGonagill, CB Bergmann… - JCI Insight, 2023 - europepmc.org
Background Sepsis remains a major clinical challenge for which successful treatment
requires greater precision in identifying patients at increased risk of adverse outcomes …
requires greater precision in identifying patients at increased risk of adverse outcomes …